Your browser doesn't support javascript.
loading
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.
Chalouni, Mathieu; Wittkop, Linda; Bani-Sadr, Firouzé; Lacombe, Karine; Esterle, Laure; Gilbert, Camille; Miailhes, Patrick; Zucman, David; Valantin, Marc Antoine; Brégigeon-Ronot, Sylvie; Morlat, Philippe; Billaud, Eric; Piroth, Lionel; Naqvi, Alissa; Sogni, Philippe; Salmon, Dominique.
Afiliação
  • Chalouni M; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.
  • Wittkop L; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.
  • Bani-Sadr F; Department of Public Health, CHU de Bordeaux, Bordeaux, France.
  • Lacombe K; Department of Internal Medicine, Clinical Immunology and Infectious Diseases, Robert Debré Hospital, University Hospital, Reims, France.
  • Esterle L; INSERM Pierre Louis Institute of Epidemiology and Public Health, IPLESP, Sorbonne University, Paris, France.
  • Gilbert C; Infectious Diseases Department, Saint-Antoine Hospital, APHP, Paris, France.
  • Miailhes P; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.
  • Zucman D; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.
  • Valantin MA; Department of Infectious and Tropical Diseases, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
  • Brégigeon-Ronot S; Internal Medicine Unit, Hôpital Foch, Suresnes, France.
  • Morlat P; Inserm, Department of Infectious Diseases, Pierre Louis Institute of Epidemiology and Public Health, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, Paris, France.
  • Billaud E; Clinical Immunohematology Department, Marseille Public University Hospital System (AP-HM), Sainte-Marguerite Hospital, Aix-Marseille University, Marseille, France.
  • Piroth L; University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, team MORPH3EUS, UMR 1219, Bordeaux, France.
  • Naqvi A; Department of Internal Medicine and Infectious Diseases, Saint André Hospital, Bordeaux University Hospital, Bordeaux, France.
  • Sogni P; Infectious Disease Unit, CHU Nantes, CIC 1413 INSERM, COREVIH, Pays de la Loire, Nantes, France.
  • Salmon D; Infectious Diseases Department, Dijon University Hospital, Dijon, France.
HIV Med ; 22(9): 791-804, 2021 10.
Article em En | MEDLINE | ID: mdl-34212476
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C / Hepatite C Crônica / Coinfecção Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HIV Med Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C / Hepatite C Crônica / Coinfecção Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HIV Med Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França